VAT refund for exempt prescription drug imports upheld despite early judicial filing; both administrative and court claims were timely filed within two years.

Taxpayers seeking VAT refunds for exempt prescription drug importations should not assume that a short gap between the administrative refund claim and the judicial appeal will automatically defeat the case, so long as both claims are filed within the mandatory two-year period and the refund is properly substantiated.

Background: Refund Claim for VAT Paid on Exempt Medicines

The dispute arose from a pharmaceutical taxpayer’s claim for refund or issuance of a tax credit certificate covering VAT allegedly paid on the importation of prescription drugs and medicines for diabetes and hypertension, as well as medicines for the treatment of cancer, mental illness, and diabetes. These goods were treated as VAT-exempt under Section 109(AA) of the National Internal Revenue Code of 1997, as amended by Republic Act Nos. 11467 and 11534.

In the original Division decision, the taxpayer’s petition was granted, and the Commissioner was ordered to refund or issue a tax credit certificate in the amount of ₱57,765,612.47, representing erroneously paid VAT on the subject importations. The Commissioner moved for reconsideration, arguing that the court supposedly lacked jurisdiction because the taxpayer failed to exhaust administrative remedies before filing its judicial claim (CTA Case No. 11076).

The Commissioner’s Main Objection: The Taxpayer Went to Court Too Soon

The Commissioner argued that the taxpayer filed its administrative refund claim on 13 January 2023 and proceeded to file its judicial claim on 25 January 2023, or only about two weeks later. From the Commissioner’s perspective, this allegedly pre-empted the BIR’s opportunity to examine, evaluate, and act on the refund request. The Commissioner maintained that judicial recourse should be available only after the BIR has had a sufficient opportunity to investigate the refund claim or after inaction within a reasonable period may be treated as a denial.

The Commissioner also challenged the evidentiary basis of the refund, asserting that the taxpayer failed to prove that the VAT payments pertained to importations of the specific VAT-exempt drugs covered by the claim. In effect, the motion for reconsideration attacked both the timing of the judicial claim and the taxpayer’s substantiation of the refund.

The Taxpayer’s Response: Both Claims Were Filed Within the Two-Year Period

The taxpayer countered that the administrative and judicial claims were both filed within the mandatory two-year prescriptive period. It also maintained that the VAT payments were erroneous because they related to imported prescription drugs and medicines that were exempt from VAT under the applicable provisions of the Tax Code, as amended.

This distinction matters for taxpayers. In VAT refund litigation, the two-year prescriptive period is often the central deadline. A taxpayer that waits too long risks losing the claim entirely. A taxpayer that files early, however, may face the opposite argument: that the administrative process was not sufficiently exhausted. The resolution addresses that tension directly.

The Ruling: A Short Interval Does Not Defeat a Timely VAT Refund Case

The motion for reconsideration was denied for lack of merit. The court held that the Commissioner raised no new issues and merely rehashed arguments already considered and rejected in the earlier decision. While the motion itself was timely filed within the applicable reglementary period, timeliness of the motion did not cure the lack of new or substantial arguments.

On the exhaustion issue, the court reiterated that it was of no moment that only a short interval existed between the filing of the administrative and judicial claims. The controlling requirement was that both claims be filed within the two-year period. Although the court acknowledged that the Commissioner may not have had sufficient opportunity to act because of the brief interval between the two filings, it emphasized that the absence of a clear statutory standard defining what counts as a reasonable period for the Commissioner to resolve tax refund claims cannot be supplied by judicial interpretation. Any such gap or insufficiency is a matter of legislative policy.

For taxpayers, this is a practical and important point. The ruling does not mean that administrative filing can be ignored. The taxpayer still filed an administrative claim. What the court rejected was the Commissioner’s position that the short interval, by itself, deprived the court of jurisdiction or defeated the refund case when both filings were made within the statutory period.

Substantiation Still Matters, But Bare Objections Are Not Enough

The Commissioner also argued that the taxpayer failed to establish that the input VAT pertained to imported drugs prescribed for the treatment of covered illnesses. The court found this contention unsubstantiated. Aside from bare assertions, the Commissioner did not specifically identify which documentary evidence was supposedly insufficient.

This part of the ruling is equally useful for refund claimants and the BIR. A VAT refund case is evidence-driven. The taxpayer must be ready to connect the VAT payments, importation documents, product classification, and statutory exemption. At the same time, an opposing challenge should be specific. A general assertion that documents are insufficient may not be enough if it does not identify the particular evidentiary defect or legal gap.

The court further stated that there was no need to repeat the analysis in the earlier decision because the motion did not raise issues warranting re-examination. It recognized that a motion for reconsideration may be dealt with generally and summarily when it merely repeats arguments already passed upon or discloses no substantial reason to modify the judgment.

Practical Takeaways for VAT Refund Claimants

First, pharmaceutical companies, importers, and other taxpayers dealing with VAT-exempt transactions should treat the two-year prescriptive period as a hard litigation deadline. Administrative and judicial claims must be planned carefully so that the taxpayer does not lose the refund through prescription.

Second, filing a judicial claim shortly after the administrative claim may still be defensible where the law does not provide a clear statutory waiting period and both claims are timely. However, this should not be treated as a substitute for careful case strategy. Taxpayers should still document the administrative claim properly and anticipate a jurisdictional objection from the Commissioner.

Third, refund claimants should prepare evidence that traces the tax paid to the exempt transaction. In drug importation cases, this may include import entries, VAT payment documents, invoices, product details, regulatory records, and proof that the goods fall within the VAT exemption for covered prescription medicines.

Fourth, taxpayers facing a motion for reconsideration should examine whether the government is raising a genuinely new issue or merely repeating arguments already resolved. Where the motion is only a rehash, the taxpayer can focus its opposition on the absence of substantial grounds to disturb the decision.

How Ablola, Saribong & Gueco Can Help

Ablola, Saribong & Gueco assists taxpayers, importers, pharmaceutical companies, and corporate groups in prosecuting and defending tax refund claims before the BIR and the Court of Tax Appeals. Our tax litigation practice helps clients evaluate refund eligibility, preserve prescriptive periods, prepare evidentiary records, respond to BIR objections, and litigate refund disputes through motions, trial, and appeal.

For businesses dealing with VAT refund claims, tax credit certificates, disputed assessments, customs issues, or Court of Tax Appeals litigation, visit MakatiLawFirm.com to consult with our tax litigation team.


Leave a Comment

Your email address will not be published. Required fields are marked *